| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
113,340,000 |
| Market
Cap: |
108.83(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.6758 - $2.34 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
41,140 |
41,140 |
| Total Buy Value |
$0 |
$0 |
$49,985 |
$49,985 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
924,350 |
1,173,939 |
1,216,699 |
1,560,865 |
| Total Sell Value |
$901,474 |
$1,198,663 |
$1,255,793 |
$3,019,031 |
| Total People Sold |
4 |
7 |
7 |
8 |
| Total Sell Transactions |
8 |
26 |
36 |
61 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smolokowski Wiaczeslaw |
10% Owner |
– – • |
2019-02-25 |
4 |
S |
$4.99 |
$3,994,880 |
D/D |
(800,000) |
6,831,267 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2019-01-07 |
4 |
AS |
$10.23 |
$127,824 |
D/D |
(12,500) |
731,134 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2019-01-07 |
4 |
OE |
$0.03 |
$413 |
D/D |
12,500 |
743,634 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2019-01-07 |
4 |
AS |
$10.23 |
$127,824 |
I/I |
(12,500) |
731,134 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2019-01-07 |
4 |
OE |
$0.03 |
$413 |
I/I |
12,500 |
743,634 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-12-07 |
4 |
AS |
$10.11 |
$126,423 |
D/D |
(12,500) |
713,510 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-12-07 |
4 |
OE |
$0.03 |
$413 |
D/D |
12,500 |
726,010 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
AS |
$10.11 |
$126,423 |
I/I |
(12,500) |
713,510 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
OE |
$0.03 |
$413 |
I/I |
12,500 |
726,010 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-11-26 |
4 |
AS |
$11.00 |
$105,600 |
I/I |
(9,600) |
512,143 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-11-26 |
4 |
OE |
$4.75 |
$45,619 |
I/I |
9,600 |
521,743 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-11-26 |
4 |
AS |
$11.00 |
$105,600 |
D/D |
(9,600) |
512,143 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-11-26 |
4 |
OE |
$4.75 |
$45,619 |
D/D |
9,600 |
521,743 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-11-19 |
4 |
AS |
$11.14 |
$4,455 |
I/I |
(400) |
512,143 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-11-19 |
4 |
OE |
$4.75 |
$1,901 |
I/I |
400 |
512,543 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-11-19 |
4 |
AS |
$11.14 |
$4,455 |
D/D |
(400) |
512,143 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-11-19 |
4 |
OE |
$4.75 |
$1,901 |
D/D |
400 |
512,543 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-11-07 |
4 |
AS |
$11.65 |
$145,593 |
I/I |
(12,500) |
713,510 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-11-07 |
4 |
OE |
$0.03 |
$413 |
I/I |
12,500 |
726,010 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-11-07 |
4 |
AS |
$11.65 |
$145,593 |
D/D |
(12,500) |
713,510 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-11-07 |
4 |
OE |
$0.03 |
$413 |
D/D |
12,500 |
726,010 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-10-18 |
4 |
AS |
$12.63 |
$126,304 |
D/D |
(10,000) |
512,143 |
|
- |
|
| Kauffman Michael |
Chief Executive Officer |
• • – |
2018-10-18 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
522,143 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-10-18 |
4 |
AS |
$12.63 |
$126,304 |
I/I |
(10,000) |
512,143 |
|
- |
|
| Shacham Sharon |
President & CSO |
• – – |
2018-10-18 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
522,143 |
|
- |
|
592 Records found
|
|
Page 14 of 24 |
|
|
0.01 (1.31%) 
